Quick Takeaways
- Adimab, LLC has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $85,667,229.
- Recent insider filing activity is available below.
- Info
- Significant Ownership
- Insider Ownership
Insider Trading & Ownership of Adimab, LLC
- Location
- Lebanon, NH
- Summary
- The estimated value of insider holdings of Adimab, LLC is at least $85,667,229 dollars as of 22 Jan 2024. Adimab, LLC is the 10%+ Owner of Invivyd, Inc. and owns shares of Invivyd, Inc. (IVVD) stock worth about $85.67M.
- Signature
- By: /s/ Philip Chase, Chief Executive Officer
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Adimab, LLC and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Invivyd, Inc. ($85,667,229).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Adimab, LLC
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IVVD | Invivyd, Inc. | 10%+ Owner | $85,667,229 | 19 Jan 2024 |
Insider Transactions Reported by Adimab, LLC:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.